A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors

Clinical trial NCT05302843 · UNKNOWN

Trial details

NCT number: NCT05302843
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastasis, Neoplasm

Start date: 2021-03-22
Primary completion: 2023-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.